Literature DB >> 22542696

Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs.

Dong-Soon Im1.   

Abstract

Omega-3 fatty acids, such as, DHA and EPA, have well established beneficial effects on human health, but their action mechanisms remain unknown. Recent pharmacological studies have suggested several molecular targets for the anti-inflammatory effects of omega-3 fatty acids, namely, nuclear receptor PPARγ and the G protein-coupled receptor GPR120. Furthermore, the conversions of omega-3 fatty acids to anti-inflammatory and pro-resolving resolvins and protectins and the identifications of putative target GPCRs, ChemR23, BLT₁, ALX/FPR2, and GPR32, have drawn great attention. In addition, the pharmacology of omega-3 fatty acids is now under scrutiny. However, questions remain to be answered regarding the in vivo effects of omega-3 fatty acids at the molecular level. In this review, anti-inflammatory effects of omega-3 fatty acids are discussed from the viewpoint of molecular pharmacology, particularly with respect to the above-mentioned GPCRs.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542696     DOI: 10.1016/j.plipres.2012.02.003

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  52 in total

Review 1.  Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.

Authors:  G Milligan; E Alvarez-Curto; K R Watterson; T Ulven; B D Hudson
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 2.  The role of specialized pro-resolving mediators in maternal-fetal health.

Authors:  E Elliott; C K Hanson; A L Anderson-Berry; T M Nordgren
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-09-23       Impact factor: 4.006

Review 3.  Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review.

Authors:  Joep W R Sins; David J Mager; Shyrin C A T Davis; Bart J Biemond; Karin Fijnvandraat
Journal:  Blood Adv       Date:  2017-08-22

4.  MAG-EPA and 17,18-EpETE target cytoplasmic signalling pathways to reduce short-term airway hyperresponsiveness.

Authors:  Rayan Khaddaj-Mallat; Éric Rousseau
Journal:  Pflugers Arch       Date:  2014-08-13       Impact factor: 3.657

5.  Ginsenoside Rb2 enhances the anti-inflammatory effect of ω-3 fatty acid in LPS-stimulated RAW264.7 macrophages by upregulating GPR120 expression.

Authors:  Qi Huang; Ting Wang; He-Yao Wang
Journal:  Acta Pharmacol Sin       Date:  2016-12-26       Impact factor: 6.150

6.  Docosahexaenoic acid enhances amphiregulin-mediated bronchial epithelial cell repair processes following organic dust exposure.

Authors:  Tara M Nordgren; Art J Heires; Kristina L Bailey; Dawn M Katafiasz; Myron L Toews; Christopher S Wichman; Debra J Romberger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-02       Impact factor: 5.464

7.  Anti-Oxidative Effects of Melatonin Receptor Agonist and Omega-3 Polyunsaturated Fatty Acids in Neuronal SH-SY5Y Cells: Deciphering Synergic Effects on Anti-Depressant Mechanisms.

Authors:  Senthil Kumaran Satyanarayanan; Yin-Hwa Shih; Yu-Chuan Chien; Shih-Yi Huang; Piotr Gałecki; Siegfried Kasper; Jane Pei-Chen Chang; Kuan-Pin Su
Journal:  Mol Neurobiol       Date:  2018-02-03       Impact factor: 5.590

Review 8.  Vein graft failure.

Authors:  Christopher D Owens; Warren J Gasper; Amreen S Rahman; Michael S Conte
Journal:  J Vasc Surg       Date:  2013-10-03       Impact factor: 4.268

9.  Liver-protecting effects of omega-3 fish oil lipid emulsion in liver transplantation.

Authors:  Xin-Hua Zhu; Ya-Fu Wu; Yu-Dong Qiu; Chun-Ping Jiang; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

10.  Enriched endogenous omega-3 fatty acids in mice protect against global ischemia injury.

Authors:  Chuanming Luo; Huixia Ren; Jian-Bo Wan; Xiaoli Yao; Xiaojing Zhang; Chengwei He; Kwok-Fai So; Jing X Kang; Zhong Pei; Huanxing Su
Journal:  J Lipid Res       Date:  2014-05-29       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.